Skip to content

Perspectives on the implementation of the ISBT 128 Standard for the Chain of Identity (CoI) Identifier

Our group of experts is working to advance the implementation of ST-028 ISBT 128 Chain of Identity (CoI) Identifier. We are drafting an article on the benefits and challenges the field has encountered or foresees in implementing the ISBT 128 CoI identifier. This survey was developed to capture different perspectives across the whole process of implementing the CoI identifier and on the solutions to these challenges.

We appreciate you taking the time and providing us with your unique perspective.
1.What is your name and email?
2.What is your primary focus in the cell and gene therapy field?(Required.)
3.Do you use a CoI Identifier in your manufacturing process?(Required.)
4.What are you using as a CoI Identifier and when/to whom is it assigned?
5.Have you implemented or are you planning on implementing the ISBT 128 CoI Identifier?(Required.)
6.What was/is the timeline for you to implement the ISBT 128 CoI Identifier?
7.Are other organizations within your supply chain using or in the process of implementing the ISBT 128 CoI Identifier?
8.Please list the benefits your organization has experienced in adopting the ISBT 128 CoI Identifier.
9.Please list the barriers your organization has encountered in implementing the ISBT 128 CoI Identifier.
10.What efforts/resources have you utilized to implement ISBT 128 CoI identifier?
11.What additional resources would support your implementation of ISBT 128 CoI identifier?
12.Is there anything else about your implementation process that you would like to share or would benefit others?